Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects. - Wikidata - wikimedia - TriplyDB

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

http://www.wikidata.org/entity/Q34657243

about

More Convoluted Than a Brazilian Soap Opera: How an Eager Chemistry Professor and a Well-Intended but Misguided Federal Judge Ignited an Industry of False Hopes.Metabolomics identifies the intersection of phosphoethanolamine with menaquinone-triggered apoptosis in an in vitro model of leukemia A "miracle" cancer drug in the era of social media: A survey of Brazilian oncologists' opinions and experience with phosphoethanolamine.Preclinical Development of a Nontoxic Oral Formulation of Monoethanolamine, a Lipid Precursor, for Prostate Cancer Treatment.Targeting Phospholipid Metabolism in Cancer.Potential antitumor activity of novel DODAC/PHO-S liposomes Ethical issues on the "synthetic" phosphoethanolamine clinical trial.Modulation of pro-apoptotic effects and mitochondrial potential on B16F10 cells by DODAC/PHO-S liposomes.Theoretical Study of Phosphoethanolamine: A Synthetic Anticancer Agent with Broad Antitumor Activity

P2860

Q33872828-99756636-FB78-441A-A533-F6331242D7C6 Q34671698-199E773B-E67D-4C88-B3CC-D38512B638D1 Q38948114-60944D18-FF38-4DDB-A49F-11481FAA0455 Q38975512-BB1B39D5-162E-44F9-A641-5A60FA1CCF60 Q39084885-CD6298F7-6C91-42C9-BA01-031AFAE198E8 Q40510633-9637C4CF-07F3-4221-8AD8-EE1B45B64C56 Q47555843-BE5DF38A-693E-438A-8741-B41E49DB5723 Q49798909-24F29653-D393-461C-9EAA-50D5188D308A Q59125515-DAE11138-CA8E-4229-9012-0F0887D367CC

P2860

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

http://www.wikidata.org/entity/Q34657243

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

@ast

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

@en

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

@nl

type

label

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

@ast

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

@en

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

@nl

prefLabel

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

@ast

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

@en

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects.

@nl

P1433

Q34657243-24BBF5EA-A88D-49B8-8822-406668C11BF9

P1476

Q34657243-00C31914-490D-4212-B17E-82F42D5A9A6A

P2093

Q34657243-39186BAB-DD15-48C4-8E2D-EBE5B65AE8F6

Q34657243-3A1BAD36-B328-41EB-932C-30C5628032E8

Q34657243-489B0F00-54F7-4140-A41A-DB2CEA727E9F

Q34657243-58D74420-2E65-4419-BDB5-26E4F468985D

Q34657243-BC6318BD-B5F3-49FC-ACA6-01E733ED4A78

P2860

Q34657243-0E399DFC-6FA8-4948-95E4-A02B7282BA5D

Q34657243-1A82E6A1-FF21-48C2-BBC4-7411DAAF80F9

Q34657243-2428ED62-560B-4F9B-A14B-88DD5A9DBB07

Q34657243-6BA3B41D-6D15-4092-928A-6CD1C4D7D7F2

Q34657243-705E0D97-5FAF-493D-A998-669BB07CB37C

Q34657243-8B8BB745-851F-44B8-8828-598B38C4DA8D

Q34657243-9007AFDA-A958-47C6-B2F3-D73229FF6354

Q34657243-9D487F8B-943C-49FE-B908-50F78FC4E8C8

Q34657243-A69B7593-EBA5-48E9-845F-DEFDBFAF34B0

Q34657243-B33DF71D-27F8-418E-838F-E4032A248A8B

P2888

Q34657243-209A9F09-72B2-4C39-A139-8FFA325004BC

P304

Q34657243-102E4DCB-21D4-421F-8038-598DC7AF894E

P31

Q34657243-1D9E0E86-FCEA-4416-8214-859211F650C6

P356

Q34657243-AEB7C478-42C5-4260-94E8-FD23A7F3543A

P407

Q34657243-EE4C5272-13FB-4DCA-B44C-D3DEB349E28B

P433

Q34657243-680AA680-16AB-435C-80FA-E64ACB6F713A

P478

Q34657243-EF67CFDA-4592-4AA3-9B51-B37A3B3CFB87

P50

Q34657243-718D2AC3-B71D-4E8D-A396-AE5B8818FF7F

P577

Q34657243-53901422-F8BD-44FC-9CA9-044D31257BB1

P5875

Q34657243-8E6134D9-0453-4F8C-B3E8-32548B41E3D3

P6179

Q34657243-9F2963D6-4D29-46E6-A8C4-D8AF3C9A66F0

P698

Q34657243-40D6844D-8EDD-44A5-B22A-7BFD991C194A

P921

Q34657243-CE0E76A1-E70B-4AE6-825B-E917A754B18A

P932

Q34657243-D030DBFA-DC28-412A-B897-EDBA65886A57

P356

P1433

British Journal of Cancer

P1476

Synthetic phosphoethanolamine has in vitro and in vivo anti-leukemia effects

@en

P2093

A K Ferreira

http://www.w3.org/2001/XMLSchema#string

B A A Santana-Lemos

http://www.w3.org/2001/XMLSchema#string

D A Maria

http://www.w3.org/2001/XMLSchema#string

G O Chierice

http://www.w3.org/2001/XMLSchema#string

O M R Filho

http://www.w3.org/2001/XMLSchema#string

P2860

Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study

Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

The membrane and lipids as integral participants in signal transduction: lipid signal transduction for the non-lipid biochemist.

Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.

Amino-ethyl phosphoric ester from tumours

Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.

Anticancer drugs targeting the mitochondrial electron transport chain.

Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway.

P2888

P304

2819-2828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2013.510

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo Magalhães Rego

P577

2013-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258348434

http://www.w3.org/2001/XMLSchema#string

P6179

1029988695

http://www.w3.org/2001/XMLSchema#string

P698

24201752

http://www.w3.org/2001/XMLSchema#string

P921

P932

3844899

http://www.w3.org/2001/XMLSchema#string